REGISTER before October 31 to benefit from significant “Early Bird” reduced rates! Details below. This year’s highly interactive conference will be offered virtually on Friday, November 28 and Saturday, November 29 and tackles common and new...| Therapeutics Initiative | Pharmacological management of dental pain and infla...
We are excited to announce that registration is now open for the 2025 annual TI Course: Bringing Best Evidence to Clinicians, happening November 28-29, 2025. The course will be offered as a virtual/online event and features a...| Therapeutics Initiative | Pharmacological management of dental pain and infla...
The live webinar has already taken place. The recording will be posted here soon. — This TI Best Evidence webinar focused on how we can think more critically about choosing antibiotic treatment durations. You can...| Therapeutics Initiative | Pharmacological management of dental pain and infla...
References Overdose & drug poisoning data [Internet]. Available from: http://www.bcehs.ca/about/accountability/data/overdose-drug-poisoning-data#Overdose–call–volumes Public Health Agency of Canada. Key findings: opioid- and stimulant-related harms in Canada [Internet]. 2019. Available from: https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/ van Amsterdam J, van den Brink W....| Therapeutics Initiative | Pharmacological management of dental pain and infla...
This live webinar has already taken place. Scroll down to view the video recording. — In this TI Best Evidence webinar, Dr. Aaron Tejani from the UBC Therapeutics Initiative provided best-practice insights on how to...| Therapeutics Initiative | Pharmacological management of dental pain and infla...
Jump to: Abstract | Full Text | Plain Language Summary | Conclusions | References Join the webinar on this topic on Wednesday, September 24th at 12:00 noon PDT [convert to your local time]. Read more...| Therapeutics Initiative | Appropriate HbA1c testing
The Therapeutics Initiative produced individual prescribing Portraits on the topic of improving how clinicians prescribe zopiclone and trazodone for insomnia (1 January 2022 to 31 December 2023). The Portraits were released online to clinicians in...| Therapeutics Initiative | Appropriate HbA1c testing
The Therapeutics Initiative produced individual prescribing Portraits on the topic of appropriate hemoglobin A1c (HbA1c) testing frequency to monitor people with type 2 diabetes (2023). The Portraits were released online to clinicians in BC who...| Therapeutics Initiative | Improving your prescribing of zopiclone and trazodo...
Jump to: Abstract | Full Text | Plain Language Summary | Patient Handout | Conclusions | References | Video Plain Language Summary Stopping antidepressants safely What is this Therapeutics Letter about? This Therapeutics Letter looks...| Therapeutics Initiative | Improving your prescribing of zopiclone and trazodo...
Jump to: Abstract | Full Text | Plain Language Summary | Conclusions | References Plain Language Summary Antidepressant withdrawal What patients and prescribers should know Bottom line: Antidepressants can be helpful for some people; but...| Therapeutics Initiative | Improving your prescribing of zopiclone and trazodo...
Therapeutics Letter| www.ti.ubc.ca
29 Jan 2025 Addressing medications that are ineffective and potentially harmful for patients with alcohol and other substance use disorders| Therapeutics Initiative
